Log In
Print this Print this

Lu 02-750

  Manage Alerts
Collapse Summary General Information
Company Axon Biochemicals B.V.
DescriptionDopaminergic agent
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationParkinson's disease (PD)
Indication DetailsTreat Parkinson's disease (PD)
Regulatory Designation
PartnerH. Lundbeck A/S

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today